Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

Hadassah Medical Organization0 个研究点目标入组 10 人开始时间: 2006年10月1日最近更新: 2006年10月4日

适应症

试验速览

阶段: 不适用
发起方: Hadassah Medical Organization
入组人数: 10
主要终点: Amount of macular edema.

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

详细描述

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations.

Patient will be operated vitrectomy, and a branch retinal vein will be punctured by small needle and rTPA 200mcg/ml will be injected to the vein.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•crvo less than 6 month
•Visual Acuity less than 6/21
•No prior eye surgery except cataract.

排除标准

•Retinal/iris neovascularization

结局指标

主要结局

Amount of macular edema.

Visual acuity

次要结局

未报告次要终点

研究者

发起方

Hadassah Medical Organization

申办方类型

Other

相似试验

招募中

2 期

Intraretinal vessel treatment for central retinal vein occlusioCetntral Retinal Artery and Vein Occlusion

JPRN-UMIN000007958Intraretinal vessel treatment for central retinal vein occlusion study team10

已完成

1 期

Phase I RVC With Ocriplasmin for CRVOCentral Retinal Vein Occlusion

NCT02747030Universitaire Ziekenhuizen KU Leuven4

已完成

3 期

Bevacizumab for Central Retinal Vein Occlusion StudyCentral Retinal Vein Occlusion

NCT00906685Anders Kvanta60

已完成

1 期

Minocycline to Treat Central Retinal Vein OcclusionRetinal Vein Occlusion

NCT01468844National Eye Institute (NEI)6

已完成

1 期

Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein OcclusionCentral Retinal Vein Occlusion

NCT01581411Weill Medical College of Cornell University1